Recent vaccination announcements have led to some confusion. Four physicians weigh in on who should get vaccinated and when ...

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...

Vaccine businesses seen as valuable parts of pharma groups but government hostility could deter future developments ...

Key Takeaways BioNTech is buying fellow German firm CureVac for approximately $1.25 billion as the COVID-19 vaccine maker ...

Robert Malone, who believes the U.S. government has “reality-bending information-control capabilities,” will guide the future ...

(HealthDay News) — The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...

BioNTech won a major shot in the arm for its cancer drug activities last week when Bristol Myers Squibb agreed to pay up to ...

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their ...